BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16292459)

  • 1. Approaches to treatment of HIV facial lipoatrophy.
    Jones D
    Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of facial lipoatrophy via autologous fat transfer.
    Cohen G; Treherne A
    J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
    Ramon Y; Fodor L; Ullmann Y
    Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restorative interventions for HIV facial lipoatrophy.
    Carey D; Liew S; Emery S
    AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical correction of HIV-associated facial lipoatrophy.
    Guaraldi G; Fontdevila J; Christensen LH; Orlando G; Stentarelli C; Carli F; Zona S; de Santis G; Pedone A; De Fazio D; Bonucci P; Martínez E
    AIDS; 2011 Jan; 25(1):1-12. PubMed ID: 20975513
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.
    Orentreich D; Leone AS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):548-51. PubMed ID: 15056149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)].
    Claude O; Domergue Than Trong E; Blanc R; Ascher B; Bagot M; Meningaud JP; Lantieri L
    Ann Chir Plast Esthet; 2009 Feb; 54(1):21-8. PubMed ID: 19042066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary surgical management of HIV-associated facial lipoatrophy.
    Funk E; Bressler FJ; Brissett AE
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
    Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
    AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial.
    Jones DH; Carruthers A; Orentreich D; Brody HJ; Lai MY; Azen S; Van Dyke GS
    Dermatol Surg; 2004 Oct; 30(10):1279-86. PubMed ID: 15458523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging a gap: surgical management of HIV-associated lipoatrophy.
    Moyle GJ
    AIDS Read; 2004 Sep; 14(9):472-5. PubMed ID: 15457598
    [No Abstract]   [Full Text] [Related]  

  • 13. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
    Doward LC; Dietz B; Wilburn J; McKenna SP; Bhor M; Rajagopalan R
    AIDS Read; 2008 May; 18(5):242-6, 252-6, 262-4. PubMed ID: 18589480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated facial lipoatrophy.
    James J; Carruthers A; Carruthers J
    Dermatol Surg; 2002 Nov; 28(11):979-86. PubMed ID: 12460289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.
    Cattelan AM; Bauer U; Trevenzoli M; Sasset L; Campostrini S; Facchin C; Pagiaro E; Gerzeli S; Cadrobbi P; Chiarelli A
    Arch Dermatol; 2006 Mar; 142(3):329-34. PubMed ID: 16549708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
    Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
    J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.
    Warde M; Gragnani A; Gomes H; Hochman B; Ferreira LM
    Int J STD AIDS; 2011 Oct; 22(10):596-9. PubMed ID: 21998182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.